EFPIA issues response to EC's Annual Growth Survey

28 November 2016

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the three main economic objectives of a strategy on what more can be done to support growth, reinforce economic convergence, create jobs and strengthen social fairness in European Union (EU) countries.

The European Commission has published the Annual Growth Survey, starting off the European Semester Cycle for 2017, which sets out the three main objectives of EU economic policy as being boosting investment, pursuing structural reforms and ensuring responsible fiscal policies.

"In an era of ageing populations and declining proportion of the working age population, it is essential to keep the workforce healthy and make sure the elderly population can enjoy high-quality lives without the burden of chronic diseases"

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK